SEC Form 4 · accession 0001250853-17-000019
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert D Montgomery
Director
Period of report
Jan 23, 2017
Accepted (ET)
Jan 25, 2017 · 6:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.40 | Jan 23, 2017 | A | 49,900 | A | — | Jan 23, 2027 | Common Stock | 49,900 | 49,900 | D |
Explanation of responses
- F1The option will vest as to 25% quarterly following the date of grant.